Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1389.4000 18.50 (1.35%)
NSE Jun 11, 2025 15:31 PM
Volume: 306.2K
 

1389.40
1.35%
IPCA LABORATORIES LTD. - 524494 - Board Meeting Outcome for To Enter Into Agreements By Bayshore …
BSE India
Entering into agreements by Bayshore Pharmaceuticals LLC, USA ('Bayshore') (wholly-owned step down subsidiary) with Unichem Laboratories Limited ('Unichem India') (subsidiary company) and Unichem Pharmaceuticals (USA) Inc ('Unichem USA') (wholly owned subsidiary of Unichem India), so as to integrate and consolidate all the Ipca Group's USA generic formulations business under one entity.
More from Ipca Laboratories Ltd.
Recommended